New Novo Nordisk initiatives support patient access to authentic, FDA-approved Wegovy® as federal ban on mass compounding of "semaglutide" takes effectPRNewsWire • 05/22/25
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugsCNBC • 05/21/25
Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (May 2025)24/7 Wall Street • 05/21/25
Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli LillyCNBC • 05/19/25
Septerna: Deal With Novo Nordisk Is A Game Changer While It Still Trades Well Below Net CashSeeking Alpha • 05/16/25
Ozempic maker Novo Nordisk ousts CEO amid plunging share price as rival Eli Lilly gains market shareNew York Post • 05/16/25